Search filters

List of works by Cliona M Rooney

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae.

scientific article published on 14 March 2018

A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cells

scientific article

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

scientific article published on 23 June 2005

A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors

scientific article published in November 2004

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

scientific article published on February 2004

A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells

scientific article published on 24 July 2019

Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).

scientific article

Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes

scientific article published on 19 October 2011

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

scientific article

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

scientific article

Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.

scientific article

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

scientific article published in September 2001

Adenoviral infections in hematopoietic stem cell transplantation

scientific article

Adenovirus as an emerging pathogen in immunocompromised patients

scientific article

Adenovirus immunity: X marks the spot

scientific article published on December 2012

Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

scientific article

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma

scientific article published in January 2006

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.

scientific article published on May 1998

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

scientific article published on July 2000

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

scientific article published on March 1994

Adoptive T-Cell Immunotherapy

scientific article

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease

scientific article published on January 2003

Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's disease

scientific article published on January 2003

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

scientific article published on June 1997

Adoptive cellular immunotherapy for viral diseases

scientific article published on 5 November 2007

Adoptive immunotherapy for EBV-associated malignancies

scientific article published on 01 January 2005

Adoptive immunotherapy for Epstein-Barr virus-related lymphoma

scientific article published on October 1996

Adoptive immunotherapy for Hodgkin's lymphoma

scientific article published on June 2006

Adoptive immunotherapy for herpesviruses ⬇️

scientific article published on February 25, 2011

Adoptive immunotherapy for posttransplantation viral infections

scientific article published on March 2004

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

scientific article (publication date: May 2016)

Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines

scientific article

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

scientific article

Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma

scientific article

Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients

scientific article published on 7 November 2013

Adoptive transfer of virus-directed T cells: will this fly for flu? ⬇️

scientific article published on December 9, 2011

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

scientific article

Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection

scientific article published on 12 October 2011

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects

scientific article

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

scientific article

An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease

scientific article

An inducible caspase 9 safety switch for T-cell therapy

scientific article published on 22 February 2005

An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy

scientific article published on 21 March 2014

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

scientific article published on 23 July 2020

Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model

scientific article published on 16 October 2015

Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection

scientific article

Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

scientific article published on September 2014

Antigen-specific T cell therapies for cancer

scientific article published on 09 July 2015

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

scientific article

Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

scientific article published on April 1995

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

scientific article published on 7 October 2011

Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor

scientific article

Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.

scientific article published in May 2006

Autoimmune disease induced by dendritic cell immunization against leukemia

scientific article published on 01 June 1999

Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection

scientific article published on August 2002

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

scientific article published on 4 November 2015

Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12.

scientific article

Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy

scientific article published on 4 November 2014

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

scientific article published on 8 June 2017

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

scientific article published in February 2000

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

scientific article

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

scientific article published on April 2015

Can Treg elimination enhance NK cell therapy for AML?

scientific article published on 01 June 2014

Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program

scientific article

Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma

scientific article published in January 1985

Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease

scientific article

Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease

scientific article published in September 2004

Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

scientific article published on March 2010

Changes in chemokine receptor expression of regulatory T cells after ex vivo culture

scientific article published on May 2012

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

scientific article

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma

scientific article published in September 2005

Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

scientific article published on 14 August 2017

Clinical grade purification and expansion of natural killer cells

scientific article

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

scientific article published on 06 June 2016

Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

scientific article

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.

scientific article

Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy

scientific article published on 17 December 2014

Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer

scientific article published on 08 January 2013

Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination

scientific article published on 30 August 2011

Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity

scientific article

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

scientific article

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells

scientific article published on 26 May 2017

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

scientific article

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.

scientific article published on 22 August 2017

Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells

scientific article published in January 2007

Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity

scientific article published on January 1997

Correction of Duncan's syndrome by allogeneic bone marrow transplantation

scientific article published on 01 September 1993

Current challenges for CAR T-cell therapy of acute myeloid leukemia

scientific article published on 14 February 2019

Cytotoxic T cells and immunotherapy

scientific article published on 01 July 1998

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

scientific article

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

scientific article published on 21 August 2009

Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

scientific article

Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma

scientific article

Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates

scientific article

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation

scientific article

Developments in clinical cell therapy

scientific article

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation

scientific article

Differential activation of cytotoxic responses by Burkitt's lymphoma (BL)-cell lines: relationship to the BL-cell surface phenotype

scientific article published in October 1986

Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines

scientific article published on May 1994

Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma

scientific article published on April 1985

Donor T cells to treat EBV-associated lymphoma

scientific article published on 01 September 1994

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

scientific article published on 12 March 2012

EBV specific CTL: a model for immune therapy

scientific article published in January 1998

EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas

scientific article

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

scientific article published on 27 September 2018

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

scientific article

Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application

scientific article

Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines

scientific article published on September 1986

Endemic and sporadic cases of Epstein-Barr virus-positive Burkitt's lymphoma: immunological characterization of derived cell lines.

scientific article published on January 1985

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

scientific article published on 29 April 2010

Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells.

scientific article published on 22 December 2017

Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.

scientific article published on October 2010

Enhancement of dendritic cells as vaccines for cancer

scientific article

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients

scientific article published on 29 October 2008

Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease

scientific article

Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy

scientific article published on 02 November 2018

Epstein-Barr infection after bone marrow transplantation

scientific article published on 01 March 1994

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas

scientific article published on January 2002

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease ⬇️

scientific article published on April 15, 1998

Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos

scientific article published on January 1989

Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma

scientific article published in March 1986

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance

scientific article

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

scientific article published in March 2002

Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells

scientific article

Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes.

scientific article

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

scientific article

Ex vivo gene transfer for improved adoptive immunotherapy of cancer

scientific article published on 17 March 2011

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients

scientific article

Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir

scientific article published on 13 January 2015

Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy

scientific article

Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15

scientific article published on 01 January 2003

Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy

scientific article published on September 2008

Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses

scientific article published on April 1989

Extensive cross-reactivity of adenovirus-specific cytotoxic T cells

scientific article published in July 1998

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications

scientific article published on 2 October 2003

Finding a way: long-term care homes to support dementia

scholarly article by Verity Faith et al published August 2015 in Institution of Civil Engineers. Proceedings. Urban Design and Planning

Fine-tuning the CAR spacer improves T-cell potency

scientific article published on 8 November 2016

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

scientific article published on 14 May 2009

Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors

scientific article published on 01 February 1996

Gene and cell transfer for specific immunotherapy

scientific article published in January 1998

Gene marking after bone marrow transplantation.

scientific article

Gene transfer and bone marrow transplantation

scientific article published on 01 January 1994

Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function

scientific article

Gene-marking and haemopoietic stem-cell transplantation

scientific article published on December 1995

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

scientific article published on 31 October 2002

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals

scientific article

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

scientific article published on 16 September 2009

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients

scientific article

Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant

scientific article published on 27 May 2011

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

scientific article published on February 2012

Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.

scientific article published on 3 March 2009

Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes

scientific article

Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency

scientific article

Genome-wide mapping of PiggyBac transposon integrations in primary human T cells

scientific article published on October 2009

Go-CART: an animal-free system for the assessment of CAR T cell function.

scientific article published on 4 November 2015

Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma

scientific article

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells

scientific article published on 30 September 2014

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

scientific article published on 20 April 2017

HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy

scientific article published in July 2005

Harnessing the immune system to potentiate oncolytics

scientific article published on February 2014

High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells

scientific article

Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.

scientific article published on October 2016

Hitchhiker's guide to the T cell

scientific article published on 01 October 2005

Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.

scientific article published on January 1992

Housing choices and care home design for people with dementia.

scientific article published on January 2015

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

scientific article published on 23 March 2015

Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

scientific article published on 15 February 2005

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.

scientific article

Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes

scientific article published on October 2003

IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity

scientific article

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

scientific article published in December 2002

Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.

scientific article

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

scientific article

Identification of protective T-cell antigens for smallpox vaccines

scientific article published on 08 May 2020

Immune therapy for EBV infections after hemopoietic stem-cell transplant

scientific article

Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation

scientific article published on September 2010

Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation

scientific article

Immunotherapy for Epstein-Barr virus-associated cancers

scientific article published in January 1998

Immunotherapy for Epstein-Barr virus-associated cancers in children

scientific article

Immunotherapy for Hodgkin's disease.

scientific article published on January 2002

Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

scientific article

Immunotherapy for post-transplant lymphoproliferative disease

scientific article

Immunotherapy to reconstitute immunity to DNA viruses

scientific article

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

scientific article published on 4 January 2017

Improving T cell therapy for cancer

scientific article

Improving T cell therapy for cancer

scientific article published on 01 January 2007

Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4

scientific article published on 9 September 2011

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas

scientific article published on 13 September 2018

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation

scientific article published in May 2006

In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye.

scientific article

Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma

scientific article published on 4 November 2015

Inducible apoptosis as a safety switch for adoptive cell therapy

scientific article (publication date: 3 November 2011)

Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation

scientific article published on 29 May 2007

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

scientific article published on 14 May 2015

Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes

scientific article

Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus

scientific article published on April 1989

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients ⬇️

scientific article published on September 1, 1998

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

scientific article published on 12 September 2013

Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma

scientific article published on 13 November 2012

Kinetics of tumor destruction by chimeric antigen receptor-modified T cells

scientific article published on 28 November 2013

Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy

scientific article published on January 2016

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

scientific article published on 17 August 2012

Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy

scientific article published on 01 May 2003

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

scientific article

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

scientific article

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

scientific article published in May 1996

Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation

scientific article

Modeling cytokine release syndrome

scientific article published on 01 June 2018

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

scientific article published on 24 September 2006

Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials

scientific article

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

scientific article published on 22 April 2013

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

scientific article published on 16 January 2019

Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation

scientific article

New insights into EBV-associated post-transplant lymphoproliferative disease

scientific article published in January 2003

New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas

scientific article published on November 1987

Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.

scientific article

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

scientific article published on 7 August 2017

Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma

scientific article published on 23 April 2020

Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes

scientific article published on October 2009

Optimizing the production of suspension cells using the G-Rex "M" series

scientific article

Options for T-cell based therapies

scientific article published on July 2004

Paired epstein-barr virus-carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non-specific and to allo-specific cytotoxic responsesin vitro ⬇️

scientific article published on September 15, 1984

Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency

scientific article published on 27 April 2015

Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.

scientific article published on 29 August 2017

Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients

scientific article

PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor

scientific article published on 19 July 2011

Post-transplant lymphoproliferative disorders

scientific article

Posttransplant lymphoproliferative disease following liver transplantation

scientific article published on June 2011

Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015: Yogyakarta, Indonesia. 4-6 June 2015.

scientific article published on 13 April 2016

Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies

scientific article

Production assistance for cellular therapies

scientific article published on 01 December 2004

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease

scientific article published on April 1995

Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant

scientific article published on January 2012

Prompt versus preemptive intervention for EBV lymphoproliferative disease

scientific article published on 29 January 2004

Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection

scientific article published in November 2006

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients

scientific article

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

scientific article

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

scientific article

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

scientific article published on 9 April 2007

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

scientific article published in June 2007

Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

scientific article published on February 2012

Reply to S. Yuan et al.

scientific article published on 21 July 2014

Reversal of tumor immune inhibition using a chimeric cytokine receptor

scientific article

Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy

scientific article published on October 2013

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

scientific article published on 14 December 2012

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

scientific article published on 20 June 2013

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

scientific article published on 22 May 2003

Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation

scientific article published on 01 June 2006

Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities

scientific article published on 14 May 2018

Structure and function of the Epstein-Barr virus BZLF1 protein

scientific article

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

scientific article

Systemic inflammatory response syndrome after administration of unmodified T lymphocytes

scientific article

T cell therapies

scientific article published on 01 January 2006

T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanisms.

scientific article published on 14 September 2010

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

scientific article published on 17 April 2009

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells

scientific article published on 22 August 2006

T lymphocytes targeting native receptors

scientific article

T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells

scientific article published on 26 September 2019

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients

scientific article

T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy

scientific article published on 20 June 2019

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

scientific article published on 17 July 2012

Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors

scientific article published on January 2006

Targeted delivery of adenoviral vectors by cytotoxic T cells

scientific article published on 25 May 2004

Targeting CD19 with genetically modified EBV-specific human T lymphocytes

scientific article

The Dynamics of Herpesvirus and Polyomavirus Reactivation and Shedding in Healthy Adults: A 14‐Month Longitudinal Study

scientific article published on 15 May 2003

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

scientific article

The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses

scientific article published on December 1992

The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.

scientific article published on July 1989

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients

scientific article

Thunder and lightning: immunotherapy and oncolytic viruses collide

scientific article

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent

scientific article published on October 2017

Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells

scientific article published on October 2014

Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system

scientific article published in February 2000

Transfection and gene expression in normal and malignant primary B lymphocytes.

scientific article published in October 1990

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant

scientific article

Transfer of marker genes into hemopoietic progenitor cells

scientific article published on September 1, 1996

Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo

scientific article published on 10 April 2018

Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.

scientific article published on July 2017

Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes

scientific article published in September 2004

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

scientific article published on 12 November 2004

Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells

scientific article

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)

scientific article published on 11 July 2006

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

scientific article published on 4 May 2015

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

scientific article published on 9 January 2018

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients

scientific article published in May 2006

Use of gene marking in bone marrow transplantation

scientific article published on 01 January 1996

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

scientific article published in January 1995

Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale

scientific article published on May 2008

Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells

scientific article published on 9 February 2017

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

scientific article (publication date: November 2008)

What influence has B-cell depletion on viral infections?

scientific article published in July 2007

piggyBac transposon system modification of primary human T cells

scientific article published on 5 November 2012

Paulina is supported by:

About Paulina

Help